サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：二重特異性抗体治療薬受託製造市場：適応症別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1419079

二重特異性抗体治療薬受託製造市場：適応症別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
二重特異性抗体治療薬受託製造市場：適応症別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

二重特異性抗体治療薬受託製造市場規模は2022年に52億8,910万米ドルとなり、2023年から2030年にかけてCAGR 36.23%で拡大する見込みです。

二重特異性抗体治療薬受託製造市場-市場力学

新規治療薬開発と研究開発投資の重点化が市場需要を促進

予測期間中、二重特異性抗体（bsAB）治療薬の受託製造市場は、主に新規治療薬の発見を目的とした研究開発努力の増加により拡大が見込まれています。同市場はここ数年で急激に拡大しており、この動向は分析期間中も続くと予想されます。その主な理由は、二重特異性抗体の強力なパイプラインであり、おそらく予測期間を通じて導入されるであろう。さらに、市場の利益拡大の主な要因は、抗がん剤治療のパイプラインが拡大していることです。例えば、米国FDAによると、2022年現在、臨床試験中の二特異性抗体の85％以上ががん治療を目的としています。

さらに、二重特異性抗体療法はがんやその他の疾患の治療において大きな治療効果が期待できるため、パンデミック以降、需要が増加しています。さらに、現在いくつかの二特異性抗体が臨床開発の初期段階にあります。したがって、今後数年間は、この点が市場成長にプラスに働くと予想されます。さらに、二重特異性抗体治療薬のパイプラインが開発中であり、市場拡大の機会を後押しすると予想されます。

二重特異性抗体治療薬受託製造市場-セグメンテーション分析：

世界の二重特異性抗体治療薬受託製造市場は、適応症、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

適応症は、がん、感染症、自己炎症性疾患、自己免疫疾患、中枢神経系疾患、その他の5つに分類されます。がん分野は市場を独占しています。がんに有効な治療法の急速な開発が、同分野の成長を後押ししています。

市場は投与経路別に、静脈内、皮下、その他の3つに分類されます。静脈内投与が市場を独占しており、予測期間中もその優位性を維持するとみられます。皮下投与経路の採用拡大が市場成長を後押しするとみられます。

市場はエンドユーザー別にバイオ製薬企業、研究機関、その他の3つに分類されます。バイオ製薬企業セグメントが市場を独占しており、予測期間中もその優位性を維持するとみられます。新薬や改良薬へのニーズの高まりが治療薬需要を押し上げています。

二重特異性抗体治療薬受託製造市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

二重特異性抗体治療薬受託製造市場-競合情勢：

二重特異性抗体治療薬受託製造市場は、その性質上、中程度の競争状態にあります。同市場の主要プレーヤーは、M&A、提携、研究開発活動など、組織内戦略的イニシアチブの採用に取り組んでいます。例えば、欧州委員会は2022年6月、CD20xCD3 T細胞結合薬bsAB Lunsumio（mosunetuzumab）の条件付き販売を承認しました。再発または抵抗性の濾胞性リンパ腫患者に適用されます。

目次

第1章 二重特異性抗体治療薬受託製造市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 二重特異性抗体治療薬受託製造の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 二重特異性抗体治療薬受託製造の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 二重特異性抗体治療薬受託製造市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 二重特異性抗体治療薬受託製造市場情勢

  • 二重特異性抗体治療薬受託製造市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 二重特異性抗体治療薬受託製造市場：適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • がん
    • 感染症
    • 自己炎症および自己免疫疾患
    • 中枢神経系の状態
    • その他

第8章 二重特異性抗体治療薬受託製造市場：投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 静脈内
    • 皮下
    • その他

第9章 二重特異性抗体治療薬受託製造市場：エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • バイオ医薬品企業
    • 研究機関
    • その他

第10章 二重特異性抗体治療薬受託製造市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 二重特異性抗体治療薬受託製造業

  • 競合ダッシュボード
  • 企業プロファイル
    • Lonza Group
    • Roche's
    • Thermo Fisher Scientific
    • Creative Biolabs
    • AbbVie
    • Amgen
    • Janssen
    • Johnson &Johnson
    • IQVIA
    • WuXi Biologics
    • Context Therapeutics
    • Sino Biological Inc.
    • KBI Biopharma
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bispecific Antibody Therapeutics Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Germany Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE India Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Brazil Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2144

REPORT HIGHLIGHT

Bispecific Antibody Therapeutics Contract Manufacturing Market size was valued at USD 5,289.1 Million in 2022, expanding at a CAGR of 36.23% from 2023 to 2030.

Therapeutics using bispecific antibodies Contract manufacturing is the practice of contracting out to specialist contract manufacturing organizations (CMOs) the manufacturing procedures involved in creating bispecific antibodies. Bispecific antibodies are a class of medicinal compounds designed to target two different antigens at the same time. These antigens are frequently found on the surface of cells that are linked to diseases such as infectious diseases, autoimmune disorders, and cancer.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Market Dynamics

Increasing emphasis on novel therapeutics development and R&D investment to propel market demand

During the forecast period, the market for contract manufacturing of bispecific antibody (bsAB) therapies is expected to grow primarily due to increased research and development efforts aimed at finding new therapeutics. The market has been seeing exponential expansion over the last few years, and this trend is expected to continue over the analysis period. The main reason for this is the strong pipeline of bispecific antibodies that will probably be introduced throughout the projection period. Moreover, a key driver of the market's profitable expansion is the expanding pipeline of anti-cancer treatments. For example, according to the U.S. FDA, more than 85% of bispecific antibodies in clinical trials are intended to treat cancer as of 2022.

Furthermore, as bispecific antibody therapies have such significant therapeutic potential in treating cancer and other disorders, there has been an increase in demand for them since the pandemic. Moreover, several bispecific antibodies are now in the early stages of clinical development. Therefore, in the upcoming years, it is anticipated that this aspect will positively affect market growth. Furthermore, there is a developing pipeline of bispecific antibody therapies, which is anticipated to boost market expansion opportunities.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.23% over the forecast period (2023-2030)
  • Based on Indication segmentation, cancer segment was predicted to show maximum market share in the year 2022, owing to high need for cancer immunotherapy.
  • Based on Route of Administration segmentation, intravenous segment was the leading segment in 2022, mainly due to its effectiveness in cancer and immune system building.
  • Based on End-User segmentation, biopharmaceutical companies' segment was the leading segment in 2022, mainly due to increasing demand from clinical trials.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high R&D and novel drugs discovery.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Segmentation Analysis:

The Global Bispecific Antibody Therapeutics Contract Manufacturing Market is segmented on the basis of Indication, Route of Administration, End-User, and Region.

The market is divided into five categories based on Indication: cancer, infectious diseases, autoinflammatory and autoimmune diseases, CNS Conditions, and others. The cancer segment dominates the market. Rapid developments in cancer effective therapies are boosting segment growth.

The market is divided into three categories based on Route of Administration: intravenous, subcutaneous, and others. The intravenous segment dominates the market and is likely to maintain its dominance during the forecast period. The growing adoption of the subcutaneous route of administration is likely to boost market growth.

The market is divided into three categories based on End-User: biopharmaceutical companies, research institutes, and others. The biopharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. Increased need for new and improved drugs is boosting the therapeutics demand.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Competitive Landscape:

Bispecific antibody therapeutics contract manufacturing market is moderately competitive in nature. The major players in the market are engaged on the adoption of in-organic strategic initiatives, such as mergers & acquisitions, partnerships, and R&D activities. For example, the European Commission authorized the conditional marketing of bsAB Lunsumio (mosunetuzumab), a CD20xCD3 T-cell binding drug, in June 2022. It will be applied to patients with relapsed or resistant follicular lymphoma.

Recent Developments:

In March 2023, InvoX Pharma Limited reported that F-star, a subsidiary of InvoX, has agreed to collaborate with Takeda on an immuno-oncology bsAB.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Roche's
  • Thermo Fisher Scientific
  • Creative Biolabs
  • AbbVie
  • Amgen
  • Janssen
  • Johnson & Johnson
  • IQVIA
  • WuXi Biologics
  • Context Therapeutics
  • Sino Biological Inc.
  • KBI Biopharma
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY INDICATION

  • Cancer
  • Infectious diseases
  • Autoinflammatory and autoimmune diseases
  • CNS Conditions
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenous
  • Subcutaneous
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY END-USER

  • Biopharmaceutical companies
  • Research institutes
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bispecific Antibody Therapeutics Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Indication
    • 2.1.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Route of Administration
    • 2.1.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by End-User
    • 2.1.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Country
    • 2.1.5. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Bispecific Antibody Therapeutics Contract Manufacturing Key Market Trends

  • 3.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunities
  • 3.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Future Trends

4. Bispecific Antibody Therapeutics Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bispecific Antibody Therapeutics Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Therapeutics Contract Manufacturing Market Landscape

  • 6.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Cancer
    • 7.1.3. Infectious diseases
    • 7.1.4. Autoinflammatory and autoimmune diseases
    • 7.1.5. CNS Conditions
    • 7.1.6. Others

8. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Intravenous
    • 8.1.3. Subcutaneous
    • 8.1.4. Others

9. Bispecific Antibody Therapeutics Contract Manufacturing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Biopharmaceutical companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Bispecific Antibody Therapeutics Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Therapeutics Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Lonza Group
    • 11.2.2. Roche's
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Creative Biolabs
    • 11.2.5. AbbVie
    • 11.2.6. Amgen
    • 11.2.7. Janssen
    • 11.2.8. Johnson & Johnson
    • 11.2.9. IQVIA
    • 11.2.10. WuXi Biologics
    • 11.2.11. Context Therapeutics
    • 11.2.12. Sino Biological Inc.
    • 11.2.13. KBI Biopharma
    • 11.2.14. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us